Advertisement

Dutch Consensus Paper: A Consensus View on the Place of Neurostimulation Within the Treatment Arsenal of Five Reimbursed Indications for Neurostimulation in The Netherlands

      Abstract

      Introduction

      After an interpretation trajectory, the Dutch Quality of Healthcare Institute recommended that for five indications, spinal cord stimulation, dorsal root ganglion stimulation, or occipital nerve stimulation, together referred to as neurostimulation, can be considered effective and be reimbursed in the Netherlands. These five indications are the well and largely studied, accepted neurostimulation indications in scientific literature.
      As an extension of this, all the scientific societies involved in the Netherlands were required to reach a consensus about the diagnosis and treatment of these five formulated indications to describe the place of neurostimulation within the treatment algorithm. This article describes the development process and content of the consensus paper.

      Materials and Methods

      A scientific committee, consisting of three anesthesiologists/pain physicians (one of whom acted as the working group’s chair), a neurosurgeon, a neurologist, a rehabilitation physician, and three nurse practitioners, participated. A quality advisor of the Knowledge Institute of the Dutch Federation of Medical Specialists supported the committee. The committee participated on behalf of their various scientific and professional societies. Three sessions were organized during which the place of neurostimulation in the treatment algorithm of the five relevant indications was discussed extensively. A narrative literature review and experts’ opinions formed the basis of decision-making in the process.

      Results

      For all five diagnoses, general and diagnosis-specific treatment requirements, conservative treatments, and minimally invasive treatments are listed. These treatments should be considered in the chronic pain management algorithm before eventually proceeding to neurostimulation.

      Discussion/Conclusion

      The content of this consensus view was discussed and compared with other literature on cost-effectiveness and the place in the algorithm of treating chronic pain. This Dutch consensus paper could ultimately contribute to the maintenance or expansion of neurostimulation and the reimbursement.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Anesthesiologie NVv
        Consensus paper Neuromodulation chronic pain, Zorg instituut Nederland. 14 November 2019, 9 February 2022 2019:271–303.
        • Guyatt G.
        • Oxman A.D.
        • Akl E.A.
        • et al.
        GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables.
        J Clin Epidemiol. 2011; 64: 383-394https://doi.org/10.1016/j.jclinepi.2010.04.026
        • Christelis N.
        • Simpson B.
        • Russo M.
        • et al.
        Persistent spinal pain syndrome: a proposal for failed back surgery syndrome and ICD-11.
        Pain Med. 2021; 22: 807-818https://doi.org/10.1093/pm/pnab015
        • Huygen F.
        • Kallewaard J.W.
        • van Tulder M.
        • et al.
        “Evidence-based interventional pain medicine according to clinical diagnoses”: update 2018.
        Pain Pract. 2019; 19: 664-675https://doi.org/10.1111/papr.12786
      1. NVA/NVR. Guideline Complex Regional Pain Syndrome type 1. 2014; Startpagina - Pijnlijke diabetische neuropathie - Richtlijn - Richtlijnendatabase. Complex_Regionaal_Pijn_Syndroom_type_1(1).pdf

      2. NIV. Guideline for Painful Diabetic Neuropathy 2017; Startpagina - Pijnlijke diabetische neuropathie - Richtlijn - Richtlijnendatabase. Pijnlijke_diabetische_neuropathie_PDNP_ (1).pdf

        • Huygen F.
        • Liem L.
        • Cusack W.
        • Kramer J.
        Stimulation of the L2–L3 dorsal root ganglia induces effective pain relief in the low back.
        Pain Pract. 2018; 18: 205-213https://doi.org/10.1111/papr.12591
        • Kumar K.
        • Taylor R.S.
        • Jacques L.
        • et al.
        The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation.
        Neurosurgery. 2008; 63 ([discussion 770].): 762-770
        • Kumar K.
        • Taylor R.S.
        • Jacques L.
        • et al.
        Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome.
        Pain. 2007; 132: 179-188https://doi.org/10.1016/j.pain.2007.07.028
        • Hunter C.W.
        • Carlson J.
        • Yang A.
        • Deer T.
        Spinal cord stimulation for the treatment of failed neck surgery syndrome: outcome of a prospective case series.
        Neuromodulation. 2018; 21: 495-503https://doi.org/10.1111/ner.12769
        • Kriek N.
        • Groeneweg G.
        • Huygen F.J.
        Burst spinal cord stimulation in a patient with complex regional pain syndrome: a 2-year follow-up.
        Pain Pract. 2015; 15: E59-E64https://doi.org/10.1111/papr.12295
        • Deer T.R.
        • Levy R.M.
        • Kramer J.
        • et al.
        Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial.
        Pain. 2017; 158: 669-681https://doi.org/10.1097/j.pain.0000000000000814
        • Slangen R.
        • Schaper N.C.
        • Faber C.G.
        • et al.
        Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial.
        Diabetes Care. 2014; 37: 3016-3024https://doi.org/10.2337/dc14-0684
        • Rock A.K.
        • Truong H.
        • Park Y.L.
        • Pilitsis J.G.
        Spinal cord stimulation.
        Neurosurg Clin N Am. 2019; 30: 169-194https://doi.org/10.1016/j.nec.2018.12.003
        • Thomson S.
        • Huygen F.
        • Prangnell S.
        • et al.
        Appropriate referral and selection of patients with chronic pain for spinal cord stimulation: European consensus recommendations and e-health tool.
        Eur J Pain. 2020; 24: 1169-1181https://doi.org/10.1002/ejp.1562
        • Levy R.M.
        Neuromodulation: the “not-so-hidden” cure for the opioid crisis.
        Neuromodulation. 2017; 20: 519-524https://doi.org/10.1111/ner.12646
        • Kumar K.
        • Hunter G.
        • Demeria D.
        Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience.
        Neurosurgery. 2006; 58 ([discussion 481–496].): 481-496
        • Poree L.
        • Krames E.
        • Pope J.
        • Deer T.R.
        • Levy R.
        • Schultz L.
        Spinal cord stimulation as treatment for complex regional pain syndrome should be considered earlier than last resort therapy.
        Neuromodulation. 2013; 16: 125-141https://doi.org/10.1111/ner.12035
        • McClure J.J.
        • Desai B.D.
        • Ampie L.
        • You W.
        • Smith J.S.
        • Buchholz A.L.
        A systematic review of the cost-utility of spinal cord stimulation for persistent low back pain in patients with failed back surgery syndrome.
        Glob Spine J. 2021; 11: 66S-72Shttps://doi.org/10.1177/2192568220970163
        • Kemler M.A.
        • Furnée C.A.
        Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy.
        Neurology. 2002; 59: 1203-1209https://doi.org/10.1212/01.wnl.0000028686.74056.e3
        • Taylor R.S.
        • Taylor R.J.
        • Van Buyten J.P.
        • Buchser E.
        • North R.
        • Bayliss S.
        The cost effectiveness of spinal cord stimulation in the treatment of pain: a systematic review of the literature.
        J Pain Symptom Manage. 2004; 27: 370-378https://doi.org/10.1016/j.jpainsymman.2003.09.009
        • Simpson E.L.
        • Duenas A.
        • Holmes M.W.
        • Papaioannou D.
        • Chilcott J.
        Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation.
        Health Technol Assess. 2009; 13 (iii, ix–x, 1–154)
        • Vyawahare B.
        • Hallas N.
        • Brookes M.
        • Taylor R.S.
        • Eldabe S.
        Impact of the National Institute for Health and Care Excellence (NICE) guidance on medical technology uptake: analysis of the uptake of spinal cord stimulation in England 2008–2012.
        BMJ Open. 2014; 4e004182https://doi.org/10.1136/bmjopen-2013-004182
        • Deer T.R.
        • Thomson S.
        • Pope J.E.
        • Russo M.
        • Luscombe F.
        • Levy R.
        International Neuromodulation Society critical assessment: guideline review of implantable neurostimulation devices.
        Neuromodulation. 2014; 17 ([discussion 685].): 678-685

      Comments